Priscoline Trademark Details
Word Mark | Priscoline |
---|---|
Status | Dead Registered 710 — Cancelled - Section 8 |
Previous Owners
Ciba- Geigy Corporation of Tarrytown, NY
View all trademarks for Ciba- Geigy CorporationCiba Pharmaceutical Products, Inc. of Summit, NJ
View all trademarks for Ciba Pharmaceutical Products, Inc.Serial Number | 71578767 |
---|---|
Registration Number | 534295 |
Status Date | Friday, April 1, 2016 |
Filing Date | Friday, April 1, 2016 |
Registration Date | Tuesday, December 5, 1950 |
Correspondent
Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609
Case File Statements
Goods & Services | Preparation Having an Action on the Circulation of the Blood |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 018 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, April 1, 2016 |
First Use Anywhere | Tuesday, March 15, 1949 |
First Use In Commerce | Tuesday, March 22, 1949 |
Primary Code | 018 |
Trademark Timeline
-
Mar 15 1949First use anywhere for the mark
-
Mar 22 1949First use in commerce for the mark
-
May 13 1949Trademark application filed with USPTO
-
Dec 05 1950Trademark officially registered with the USPTO
-
Dec 05 1970Registered and Renewed (first Renewal - 20 Yrs)
-
Oct 26 1990Registered - Sec. 9 Filed/check Record For Sec. 8
-
Nov 28 1990Registered and Renewed (second Renewal - 10 Yrs)
-
Jun 26 2000Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
-
Jun 26 2000Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
-
Feb 01 2001Registered and Renewed (third Renewal - 10 Yrs)
-
Feb 01 2001Registered - Sec. 8 (10-Yr) Accepted/sec. 9 Granted
-
Nov 18 2004Paper Received
-
Dec 04 2004Teas Change of Correspondence Received
-
Oct 15 2008Case File In Ticrs
-
Jun 17 2009Teas Change of Correspondence Received
-
Oct 07 2009Case Assigned To Post Registration Paralegal
-
Oct 16 2009Review of Correspondence Complete
-
Apr 01 2016Cancelled Sec. 8 (10-Yr)/expired Section 9